🇺🇸 FDA
Patent

US 10669312

Peptide for suppressing osteoclast differentiation and use thereof

granted A61KA61K38/00A61K38/04

Quick answer

US patent 10669312 (Peptide for suppressing osteoclast differentiation and use thereof) held by CAREGEN CO., LTD. expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K38/04, A61K38/10, A61P